StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)

Close on Nov 17, 2026Market cap $4.78MP/E –Yield –

Cerenome enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Cerenome's enterprise value was -$2.73M on Nov 11, 2026, against $63.68M a year earlier. Over the last 5 years it ranged from -$14.18M to $983.31M, with a median of $1.03M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$2.73M-105.4%
2025Dec 31, 2025$50.82M+2450.2%
2024Dec 31, 2024$1.99M+58.5%
2023Dec 29, 2023$1.26M–
2022Dec 30, 2022-$13.86M–
2021Dec 31, 2021-$13.45M–
2020Dec 31, 2020-$826.68K–
2019Dec 31, 2019-$5.44M-173.3%
2018Dec 31, 2018$7.43M-21.1%
2017Dec 29, 2017$9.41M+107.7%
2016Dec 30, 2016$4.53M–

More Cerenome figures

See a number that looks wrong?